Investor Presentation for Half and Financial Year ended 31st March 2026
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Star Imaging and Path Lab reported FY26 revenue of Rs 88.5 crores, up 6% YoY, with EBITDA of Rs 33.2 crores growing 16% and margins expanding 320 basis points to 37.5%. PAT came in at Rs 19.2 crores, up 20% YoY, with PAT margin improving to 21.5% from 19.1%. Cashflow from operations turned positive at Rs 23.4 crores versus negative Rs 2.6 crores in FY25. The company operates 24 diagnostic centers across Delhi, Uttar Pradesh, and Nashik. B2B network expanded to 100+ hospital tie-ups, and a new B2C center is being set up in Dwarka (operational by H1 FY27). Management explicitly guided 25-30% YoY growth rate for upcoming years. Balance sheet shows net cash position with net debt to equity of negative 0.3x.
Strong operational execution with margin expansion and positive cash generation signals healthy business growth. The explicit 25-30% YoY growth guidance for upcoming years provides clear visibility for shareholders, and the net cash position reduces financial risk.